Augustinus investment concluded successfully
The investment in Abacus Medicine by Chr. Augustinus Fabrikker has today been concluded successfully.
Following the expected approval by the competition authorities in Denmark (Konkurrence- og Forbrugerstyrelsen) and in Germany (Bundeskartellamt) the remaining paperwork was completed on Monday, September 16th.
Chr. Augustinus Fabrikker invests EUR 48 million to acquire an ownership stake of just over one third of the shares in Abacus Medicine. Flemming Wagner continues as the company’s CEO and majority shareholder.
We are happy to help, so please get in touch. Below you will find our main offices, but we have people covering all of Europe.
1620 Copenhagen V
Maglódi út 6
Berliner Straße 8
282 Farnborough Road
Farnborough GU14 7NA
12/14 Rond-Point des Champs-Elysées
Paris 75008, France